This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 2025 conversion factor (CF) that sets the overall rate for the Medicare Physician Fee Schedule (MPFS) was adjusted downward by 2.83% from the 2024 rate, to $32.3465 per RVU vs. $33.2875 per Relative Value Unit (RVU). Several bills are pending in Congress that would mitigate the scheduled reduction, at least on a temporary basis, or perhaps to make more permanent corrections to the Medicare pricing formula.
The U.S. Department of Treasury will not enforce the Corporate Transparency Act come March 21, but the underlying law remains in effect, cautioned the American College of Radiology (ACR) in a March 14 bulletin. Companies doing business in the U.S. -- including ACR member companies, radiology practices, and imaging centers -- were preparing to have to disclose to the U.S. government information about the individuals who own or control them, although some could be exempt, ACR noted in a previous b
Manisha Bahl, MD, explained that ChatGPT and other large language models offer significant potential to help radiologists with breast imaging exams, but they are "not quite ready for primetime.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Shuttle Pharmaceuticals Holdings has closed a previously announced underwritten public common stock offering, with aggregate gross proceeds of approximately $5.8 million. The Gaithersburg, MD-based specialty pharmaceutical company offered 19.1 million shares of its common stock at a public offering price of 30 per share. WestPark Capital acted as the sole book-runner in connection with the offering.
In a prospective study involving 54 adults, ultralow-dose CT, denoised with deep learning, substantially cut radiation exposure while accurately detecting pneumonia.
In a prospective study involving 54 adults, ultralow-dose CT, denoised with deep learning, substantially cut radiation exposure while accurately detecting pneumonia.
The Healthcare Information and Management Systems Society (HIMSS) annual conference always brings forward valuable conversations, but this years event stood out for the depth of executive engagement and the evolving expectations around AI in healthcare. Its clear that the industry is moving beyond technology alone. Leaders want solutions that dont just check a box but drive real impact at scale.
AI is making its mark across healthcare fields, with over 1,000 AI models now cleared by the FDA. A large portion of these advancements directly impact cardiologymore specifically, cardiac sonography. Interpreting cardiac ultrasounds has become more complex and time-consuming for clinicians: With the shift toward a more quantitative analysis, there are more parameters for clinicians to measure.
Deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumor clusters (VETC) in hepatocellular carcinoma (HCC) -- a tumor form linked to poor patient outcomes, according to a study published March 14 in Radiology: Imaging Cancer. The models can also assess the risk for early recurrence and progression-free survival, noted a team led by Yixing Yu, MD, of the First Affiliated Hospital of Soochow University in Suzhou, China.
For years, the subspecialty has grappled with decreasing trainee interest, rising volumes and staffing demands, and a competitive market for talent, experts write in JACR.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Yttrium-90 transarterial radioembolization (Y-90 TARE) improved survival rates compared to transarterial hepatic embolization (TAE) without Y-90 in patients with large liver tumors, according to a recent study. The finding is from a retrospective assessment of the two minimally invasive procedures in patients with tumors larger than 7 cm. This research found that patients who underwent Y-90 TARE rather than TAE lived more than eight months longer, noted lead author Sam Son, MD, of Memorial Sloan
For immunocompromised individuals, denoised ultra-low-dose CT offers similar detail as normal-dose CT scans for pneumonia detection, according to a recent study.
Advanced visualization software developer Ziosoft has formed a strategic partnership with medical technology firm Olympus. Under the deal, Olympus will be utilizing the firms Revoras image analysis platform as an AI-powered clinical decision tool for preoperative surgical planning. The platform will be launched by Olympus in parallel to its Intelligent Endoscopy Ecosystem, according to the companies.
Environment and mental health interact daily, shaping emotions, productivity, social connections, sleep patterns, and overall resilience. The post Place Matters: How Your Environment Affects Your Mental Health appeared first on Open MedScience.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Bi-partisan legislation introduced March 13 reasserted the Radiation Oncology Case Rate (ROCR) Value-Based Payment Program, proposing to exempt it from budget neutrality adjustment requirements. Introduced by Sens. Thom Tillis (R-NC), Gary Peters (D-MI), and others, S 1031 , the ROCR Act of 2025 proposes key provisions that favor patient-specific episode-based payments, shorter evidence-based treatments, quality and safety standards, practice accreditation, and free or discounted transportation
Chemotherapy for cancer treatment targets rapidly growing cancer cells but can also harm healthy cells, causing side effects. The post Chemotherapy to Treat Cancer: How Does It Work? appeared first on Open MedScience.
Diagnostic Imaging in Sports Medicine helps accurately diagnose injuries, guiding effective treatment and optimising athlete recovery timelines. The post The Role of Diagnostic Imaging in Sports Medicine and Injury Recovery appeared first on Open MedScience.
Health industry innovations, such as AI, VR, robotics, wearables, and chatbots, are revolutionising modern healthcare and treatment. The post 5 Technologies Revolutionizing the Global Health Industry appeared first on Open MedScience.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
130 
Let's personalize your content